The objective of this study was to evaluate the safety and performance of the artificial pancreas (AP) in adolescents with type 1 diabetes (T1D) following insulin omission for food.In a randomized, cross-over trial, adolescents with T1D aged 13-18 yr were enrolled in a randomized, cross-over trial. On separate days, received either usual care (UC) through their home insulin pump or used an AP system (Diabetes Assistant platform, continuous glucose monitor, and insulin pump). Approximately 1 h after admission, participants in both groups received an unannounced snack of 30 g carbohydrate, and 4 h later they received an 80 g lunch, for which both groups only received 75

作者：Daniel R, Cher?avvsky；Mark D, DeBoer；Patrick, Keith-Hynes；Benton, Mize；Molly, McElwee；Susan, Demartini；Spencer F, Dunsmore；Christian, Wakeman；Boris P, Kovatchev；Marc D, Breton

来源：Pediatric diabetes 2016 年 17卷 1期